These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32392359)

  • 1. Epidemiology of multiple sclerosis in Santiago de Compostela (Spain).
    Costa Arpín E; Naveiro Soneira J; Lema Bouzas M; González Quintela A; Prieto González JM
    Acta Neurol Scand; 2020 Sep; 142(3):267-274. PubMed ID: 32392359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of multiple sclerosis in Santiago de Compostela (Galicia, Spain).
    Ares B; Prieto JM; Lema M; Dapena D; Arias M; Noya M
    Mult Scler; 2007 Mar; 13(2):262-4. PubMed ID: 17439895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological study of multiple sclerosis in La Rioja.
    Bártulos Iglesias M; Marzo Sola ME; Estrella Ruiz LA; Bravo Anguiano Y
    Neurologia; 2015; 30(9):552-60. PubMed ID: 24975346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.
    Grytten N; Aarseth JH; Lunde HM; Myhr KM
    J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):100-5. PubMed ID: 25714916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal trends in the incidence and prevalence of Multiple Sclerosis in the Northwest of Spain.
    Costa-Arpín E; Ares B; González-Quintela A; Prieto-González J
    Mult Scler Relat Disord; 2021 Jul; 52():102979. PubMed ID: 33964571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR study.
    Sıvacı AÖ; Seferoğlu M; Piri Çınar B; Uzunköprü C; Beckmann Y; Güngör Doğan İ; Çetinkaya Tezer D; Tunç A; Ethemoğlu Ö; Gümüş H; Açıkgöz M; Yalaz Tekan Ü; Demir S
    Mult Scler Relat Disord; 2024 Apr; 84():105469. PubMed ID: 38341979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
    Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of multiple sclerosis in the province of Teruel, Spain.
    Modrego Pardo PJ; Latorre MA; López A; Errea JM
    J Neurol; 1997 Mar; 244(3):182-5. PubMed ID: 9050959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.
    O'Connell K; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2017 Apr; 13():75-80. PubMed ID: 28427707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of multiple sclerosis in Health District III, Murcia, Spain.
    Candeliere-Merlicco A; Valero-Delgado F; Martínez-Vidal S; Lastres-Arias Mdel C; Aparicio-Castro E; Toledo-Romero F; Villaverde-González R
    Mult Scler Relat Disord; 2016 Sep; 9():31-5. PubMed ID: 27645340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis in Móstoles, central Spain.
    Benito-León J; Martin E; Vela L; Villar ME; Felgueroso B; Marrero C; Guerrero A; Ruiz-Galiana J
    Acta Neurol Scand; 1998 Oct; 98(4):238-42. PubMed ID: 9808272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epilepsy in multiple sclerosis: A nationwide population-based register study.
    Burman J; Zelano J
    Neurology; 2017 Dec; 89(24):2462-2468. PubMed ID: 29117950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent increase in the prevalence and female ratio of multiple sclerosis over 15 years in northern Japan.
    Houzen H; Kondo K; Horiuchi K; Niino M
    Eur J Neurol; 2018 Feb; 25(2):334-339. PubMed ID: 29105222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence and increasing incidence of multiple sclerosis in the Norwegian county of Buskerud.
    Simonsen CS; Edland A; Berg-Hansen P; Celius EG
    Acta Neurol Scand; 2017 Apr; 135(4):412-418. PubMed ID: 27241360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term epidemiology of multiple sclerosis in the Northern Seville District.
    Izquierdo G; Venegas A; Sanabria C; Navarro G
    Acta Neurol Scand; 2015 Aug; 132(2):111-7. PubMed ID: 25649860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic and clinical profile of Multiple Sclerosis in Kashmir: A short report.
    Zahoor I; Asimi R; Haq E; Yousuf Wani I
    Mult Scler Relat Disord; 2017 Apr; 13():103-106. PubMed ID: 28427689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis prevalence and incidence in San Vicente del Raspeig, Spain.
    Perez-Carmona N; Gimenez-Martinez J; Borrego-Honrubia C; Sempere AP
    Mult Scler Relat Disord; 2019 Aug; 33():78-81. PubMed ID: 31170564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and prevalence of multiple sclerosis in Newfoundland and Labrador.
    Sloka JS; Pryse-Phillips WE; Stefanelli M
    Can J Neurol Sci; 2005 Feb; 32(1):37-42. PubMed ID: 15825544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrád County, Hungary.
    Bencsik K; Rajda C; Füvesi J; Klivényi P; Járdánházy T; Török M; Vécsei L
    Eur Neurol; 2001; 46(4):206-9. PubMed ID: 11721128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of multiple sclerosis in Sardinia: A systematic cross-sectional multi-source survey.
    Urru SA; Antonelli A; Sechi GM;
    Mult Scler; 2020 Mar; 26(3):372-380. PubMed ID: 30793660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.